Status:
UNKNOWN
Placenta Perfusion and Sufficiency Study
Lead Sponsor:
Maxima Medical Center
Conditions:
Placenta Diseases, Diagnosis
Pregnancy Related
Eligibility:
FEMALE
18-40 years
Brief Summary
Ultrasonography will be used to determine the total blood flow to and from the uterus. This is done by measuring the blood vessels coming from and going to the uterus. This wil hopefully prove viable ...
Detailed Description
This prospective pilot study takes place between 14- and 16-weeks' gestation (GA14 to 16 weeks). This is a feasibility study, as the perfusion measurements have not yet been performed this early in pr...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Between 14-16 weeks gestation on measurement day
- Placenta anterior
- BMI \< 30kg/m2
- Ability to give consent
- Adequate mastery of the Dutch or English languages
Exclusion
- Non-intact pregnancy at 13 week's gestational echo.
- Vanishing twin
- Multiple gestations
- Congenital or anatomical anomalies at 13 weeks' gestational echo.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06042348
Start Date
September 15 2023
End Date
January 31 2024
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maxima Medical Center
Veldhoven, Braband, Netherlands